oyageninc.com
OyaGen | HIV drug discovery towards a cureHIV drug discovery towards a cure. Is a biotechnology company formed on September 5, 2003, for the purpose of discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. OyaGen holds exclusive rights to important technologies originating from the University of Rochester Medical Center (URMC), the Thomas Jefferson University (TJU) and those filed by the company independently. Trends in Biochemical Sciences, Cell Press.
http://www.oyageninc.com/